ArticleOPEN ACCESS

Editorial: Harnessing chemotherapy resistance and development of novel therapeutic strategies for acute leukemia with KMT2A (MLL)-gene rearrangements

Frontiers in Pharmacology
DOI: 10.3389/fphar.2022.977741
0Citations
Citations of this article
5Readers
Mendeley users who have this article in their library.

Author supplied keywords

Cite

CITATION STYLE

APA

Esposito, M. T., Hagström-Andersson, A., Stam, R. W., & Bortoluzzi, S. (2022, August 8). Editorial: Harnessing chemotherapy resistance and development of novel therapeutic strategies for acute leukemia with KMT2A (MLL)-gene rearrangements. Frontiers in Pharmacology. Frontiers Media S.A. https://doi.org/10.3389/fphar.2022.977741

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free